626 related articles for article (PubMed ID: 29043538)
21. Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants.
Vedovati MC; Giustozzi M; Becattini C
Thromb Res; 2019 May; 177():33-41. PubMed ID: 30849513
[TBL] [Abstract][Full Text] [Related]
22. Treatment of venous thromboembolism.
Wells PS; Forgie MA; Rodger MA
JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism in the medically ill patient: a call to action.
Bergmann JF; Kher A
Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
[TBL] [Abstract][Full Text] [Related]
24. The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients.
Dobesh P
Int J Clin Pract; 2010 Oct; 64(11):1554-1562. PubMed ID: 20846203
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulant selection for patients with VTE-Evidence from a systematic literature review of network meta-analyses.
Cohen AT; Berger SE; Milenković D; Hill NR; Lister S
Pharmacol Res; 2019 May; 143():166-177. PubMed ID: 30905806
[TBL] [Abstract][Full Text] [Related]
27. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis.
Vedovati MC; Giustozzi M; Bonitta G; Agnelli G; Becattini C
Thromb Res; 2018 Oct; 170():175-180. PubMed ID: 30196195
[TBL] [Abstract][Full Text] [Related]
29. Thromboprophylaxis in nonsurgical patients.
Streiff MB; Lau BD
Hematology Am Soc Hematol Educ Program; 2012; 2012():631-7. PubMed ID: 23233645
[TBL] [Abstract][Full Text] [Related]
30. Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial.
Pai M; Adhikari NKJ; Ostermann M; Heels-Ansdell D; Douketis JD; Skrobik Y; Qushmaq I; Meade M; Guyatt G; Geerts W; Walsh MW; Crowther MA; Friedrich JO; Burry L; Bellomo R; Brandão da Silva N; Costa Filho R; Cox MJ; Alves Silva S; Cook DJ;
PLoS One; 2018; 13(6):e0198285. PubMed ID: 29856817
[TBL] [Abstract][Full Text] [Related]
31. Use of Prophylaxis for Prevention of Venous Thromboembolism in Patients with Isolated Foot or Ankle Surgery: A Systematic Review and Meta-Analysis.
Bikdeli B; Visvanathan R; Jimenez D; Monreal M; Goldhaber SZ; Bikdeli B
Thromb Haemost; 2019 Oct; 119(10):1686-1694. PubMed ID: 31430799
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
[TBL] [Abstract][Full Text] [Related]
33. DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines.
Neumann I; Izcovich A; Zhang Y; Rada G; Kahn SR; Spencer F; Rezende S; Dentali F; Bauer K; Morgano GP; Yepes-Nuñez JJ; Nieuwlaat R; Wiercioch W; Lu L; Wu J; Cushman M; Schunemann H
Blood Adv; 2020 Apr; 4(7):1512-1517. PubMed ID: 32289163
[TBL] [Abstract][Full Text] [Related]
34. Real-World Comparative Effectiveness and Cost Comparison of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin in 376,858 Medically Ill Hospitalized US Patients.
Veeranki SP; Xiao Z; Levorsen A; Sinha M; Shah BR
Am J Cardiovasc Drugs; 2021 Jul; 21(4):443-452. PubMed ID: 33313988
[TBL] [Abstract][Full Text] [Related]
35. Prevention of venous thromboembolism in patients with cancer with direct oral anticoagulants: A systematic review and meta-analysis.
Chen H; Tao R; Zhao H; Jiang J; Yang J
Medicine (Baltimore); 2020 Jan; 99(5):e19000. PubMed ID: 32000440
[TBL] [Abstract][Full Text] [Related]
36. VTE Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis.
Fernando SM; Tran A; Cheng W; Sadeghirad B; Arabi YM; Cook DJ; Møller MH; Mehta S; Fowler RA; Burns KEA; Wells PS; Carrier M; Crowther MA; Scales DC; English SW; Kyeremanteng K; Kanji S; Kho ME; Rochwerg B
Chest; 2022 Feb; 161(2):418-428. PubMed ID: 34419428
[TBL] [Abstract][Full Text] [Related]
37. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency.
Dolovich LR; Ginsberg JS; Douketis JD; Holbrook AM; Cheah G
Arch Intern Med; 2000 Jan; 160(2):181-8. PubMed ID: 10647756
[TBL] [Abstract][Full Text] [Related]
38. Extended duration of thromboprophylaxis for medically ill patients: a systematic review and meta-analysis of randomised controlled trials.
Zayed Y; Kheiri B; Barbarawi M; Banifadel M; Abdalla A; Chahine A; Obeid M; Haykal T; Yelangi A; Malapati S; Bachuwa G; Seedahmed E
Intern Med J; 2020 Feb; 50(2):192-199. PubMed ID: 31276276
[TBL] [Abstract][Full Text] [Related]
39. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors.
Jones A; Al-Horani RA
Med Sci (Basel); 2023 Aug; 11(3):. PubMed ID: 37606428
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
